Sanjivani Paranteral Ltd Q3 FY26 results deck summary

Results deck of 13 Jan 2026, summarised by AI from the filing.

Sanjivani Paranteral Q3 FY26 standalone revenue ₹208.6 mn, up 20.3% Y-o-Y, PAT ₹26.2 mn, up 37.8% Y-o-Y.

Key takeaways

1. Q3 FY26 revenue Standalone revenue from operations ₹208.6 mn, up 20.3% Y-o-Y from ₹173.5 mn in Q3 FY25.
2. Q3 FY26 PAT Standalone PAT ₹26.2 mn, up 37.8% Y-o-Y from ₹19.0 mn in Q3 FY25.
3. Gross margin Standalone gross margin fell to 33.4% in Q3 FY26 from 44.6% in Q3 FY25, a decline of 1116 bps.
4. Segment mix Injectables revenue ₹129.9 mn in Q3 FY26, up from ₹86.4 mn in Q3 FY25; orals ₹34.1 mn and nutraceuticals ₹5.6 mn.
5. Geographic mix Exports were 76.9% and domestic 23.1% of standalone revenue in Q3 FY26.

Original filing on BSE

Sanjivani Paranteral Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (14 Aug 2026), Results press release (14 Aug 2026)
• Q4 FY26: Earnings call (15 May 2026), Results deck (14 May 2026)
• Q3 FY26: Earnings call (16 Feb 2026), Results deck (13 Jan 2026), Results press release (16 Feb 2026)
• Q2 FY26: Earnings call (19 Nov 2025), Results deck (18 Nov 2025), Results press release (15 Nov 2025)
• Q1 FY26: Earnings call (12 Aug 2025), Results deck (12 Aug 2025), Results press release (12 Aug 2025)
• Q4 FY25: Earnings call (27 May 2025), Results press release (27 May 2025)
• Q3 FY25: Results deck (27 Feb 2025)